BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24334819)

  • 21. Value of immunohistochemistry in confirming undifferentiated ovarian carcinomas.
    Georgescu CV; Florescu M; Simionescu C
    Rom J Morphol Embryol; 1999-2004; 45():133-42. PubMed ID: 15847387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiosarcomas of Primary Gynecologic Origin - A Case Series and Review of the Literature.
    Chinczewski L; Taube ET; Feldhaus FW; DrĂ–ge LA; Chekerov R; Muallem MZ; Pietzner K; Sehouli J; Alavi S
    Anticancer Res; 2020 Oct; 40(10):5743-5750. PubMed ID: 32988901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Peritoneal carcinosis in ovarian cancer: conventional imaging (CT-scan and MRI)].
    Bailly C; Bailly-Glatre A; Alfidja A; Vincent C; Dauplat J; Pomel C
    Bull Cancer; 2009 Dec; 96(12):1155-62. PubMed ID: 19959422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urachal mucinous cystadenocarcinoma with a cystic ovarian metastasis.
    Yanagisawa S; Fujinaga Y; Kadoya M
    AJR Am J Roentgenol; 2003 Apr; 180(4):1183-4. PubMed ID: 12646487
    [No Abstract]   [Full Text] [Related]  

  • 25. [Peritoneal carcinomatosis].
    Coelho SS; Silva PM; Ramos J
    Acta Med Port; 1998 Jun; 11(6):585-9. PubMed ID: 9773541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment outcomes for advanced ovarian cancers with peritoneal dissemination].
    Oe S; Hasegawa K; Ichikawa R; Torii Y; Kato R; Komiyama S; Udagawa Y
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):591-7. PubMed ID: 21498987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Huge peritoneal malignant mesothelioma mimicking primary ovarian carcinoma.
    Tangjitgamol S; Warnnissorn M; Attakettaworn K; Puripat N
    J Med Assoc Thai; 2013 Jan; 96(1):107-11. PubMed ID: 23720986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiosarcoma arising in mature cystic teratoma of the ovary: a case report and review of the literature.
    Contreras AL; Malpica A
    Int J Gynecol Pathol; 2009 Sep; 28(5):453-7. PubMed ID: 19696615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary ovarian angiosarcoma--review of the literature and report of a case with coexisting chylothorax.
    Vavilis D; Papadopoulos N; Agorastos T; Efstratiou I; Kommoss F; Bontis IN
    Eur J Gynaecol Oncol; 2007; 28(4):287-9. PubMed ID: 17713094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary angiosarcoma of the ovary complicated by hemoperitoneum: a case report and review of the literature.
    Bradford L; Swartz K; Rose S
    Arch Gynecol Obstet; 2010 Jan; 281(1):145-50. PubMed ID: 19396453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intralesional topotecan in advanced ovarian cancer: a clinical report, based on a preclinical study.
    Nicoletto MO; Padrini R; Palumbo M; Ziade A; Ragazzi RS; Pratesi G; Artioli G; De Cesare M; Zunino F
    Oncol Rep; 2002; 9(6):1351-4. PubMed ID: 12375047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastric epithelioid angiosarcoma, a biopsy diagnostic pitfall].
    Amy C; Lazure T; Sales JP; Languille-Mimoune O; Callard P; Bedossa P; Fabre M
    Ann Pathol; 2001 Oct; 21(5):439-41. PubMed ID: 11852364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer.
    Chan JK; Lin SS; McMeekin DS; Berman ML
    J Clin Oncol; 2005 Sep; 23(27):6794-5. PubMed ID: 16170188
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
    Schilder RJ; Sill MW; Lee RB; Shaw TJ; Senterman MK; Klein-Szanto AJ; Miner Z; Vanderhyden BC
    J Clin Oncol; 2008 Jul; 26(20):3418-25. PubMed ID: 18612157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.
    Pan HS; Lee SL; Huang LW; Chen YK
    Arch Gynecol Obstet; 2011 Feb; 283(2):335-41. PubMed ID: 20221620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer.
    Cascales Campos P; Gil J; Parrilla P
    Eur J Surg Oncol; 2014 Aug; 40(8):970-5. PubMed ID: 24035502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cutaneous angiosarcoma arising after radiotherapy treatment of a breast carcinoma. Description of a case and review of the literature].
    Di Tommaso L; Fabbri A
    Pathologica; 2003 Aug; 95(4):196-202. PubMed ID: 14577204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin.
    Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2004 Apr; 30(3):280-5. PubMed ID: 15028309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
    Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
    Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiosarcoma of the scalp and face: failure of an interferon alpha treatment.
    Guillot B; Raison-Peyron N; Acevedo M; Meunier L; Dandurand M; Meynadier J
    Eur J Dermatol; 2000 Jun; 10(4):300-2. PubMed ID: 10846259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.